The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Eric D AdlerGordon Keller

Abstract

We recently described a murine embryonic stem cell (ESC) line engineered to express the activated Notch 4 receptor in a tetracycline (doxcycline; Dox) regulated fashion (tet-notch4 ESCs). Notch 4 induction in Flk1(+) hematopoietic and vascular progenitors from this line respecified them to a cardiovascular fate. We reasoned that these cells would be ideal for evaluating the contribution of the cardiomyocyte and vascular lineages to the functional improvement noted following stem cell transplantation in infarcted hearts. Flk-1(+) Tet-notch4 cells from d 3 embryoid bodies exposed to doxycycline (Dox(+)) were compared to uninduced (Dox(-)) Flk-1(+) cells. Mice underwent transplantation of 5 x 10(5) Dox(+) cells, Dox(-)cells, or an equal volume of serum-free medium after surgically induced myocardial infarction. The mean ejection fraction was 59 + or - 15, 46 + or - 17, and 39 + or - 13% in the Dox(+), Dox(-), and serum-free medium groups, respectively (P<0.05 for the differences among all 3 groups). Immunohistochemistry of hearts injected with Dox(+) grafts expressed myocardial and vascular markers, whereas grafts of Dox(-) cells expressed primarily vascular markers. We conclude that cardiovascular progenitors are more effective t...Continue Reading

References

Jan 25, 2002·Current Controlled Trials in Cardiovascular Medicine·Doris A Taylor
Jul 26, 2002·Progress in Cardiovascular Diseases·Marc S PennEric J Topol
Oct 28, 2003·The Journal of Physiology·Jürgen F HeubachUrsula Ravens
Feb 10, 2004·The Journal of Physiology·Virginijus ValiunasIra S Cohen
May 26, 2004·The Journal of Biological Chemistry·Hina W ChaudhryDebra J Wolgemuth
Sep 28, 2004·Nature Biotechnology·Izhak KehatLior Gepstein
Sep 13, 2006·Clinical Genetics·A J Rusnak, A E Chudley
Nov 30, 2006·Annals of the New York Academy of Sciences·Michael Rubart, Loren J Field
Dec 19, 2006·Methods in Molecular Biology·Timothy D O'ConnellPaul C Simpson
May 30, 2007·Archives of Internal Medicine·Ahmed Abdel-LatifBuddhadeb Dawn
Oct 5, 2007·American Journal of Physiology. Cell Physiology·Jennifer L HoardRobert Wondergem
Sep 6, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinsuke Yuasa, Keiichi Fukuda
Sep 30, 2008·Nature Biotechnology·Vincent C ChenGordon Keller

❮ Previous
Next ❯

Citations

Jun 26, 2013·Journal of Cardiovascular Translational Research·James E Hudson, Enzo R Porrello
Aug 25, 2011·Stem Cell Research & Therapy·Jennifer K Redig, Eric Adler
Jul 19, 2012·Journal of Cardiovascular Translational Research·Pieterjan DierickxLinda W van Laake
Jul 13, 2011·Journal of Cardiovascular Translational Research·Sara S NunesMilica Radisic
May 10, 2015·Advanced Drug Delivery Reviews·Nicole T Feric, Milica Radisic
Jun 26, 2010·European Journal of Heart Failure·Ibrahim J DomianPeter van der Meer
Jan 8, 2011·Circulation Research·Michela NosedaMichael D Schneider
Oct 6, 2018·Nature Reviews. Cardiology·Donal MacGroganJosé Luis de la Pompa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.